Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells

Biochemical Pharmacology

Volumn 74, Issue 11, 2007, Pages 1642-1651

  Kim, So Young ^a   Kim, Dong Hyun ^b   Han, Sang Jun ^b   Hyun, Jin Won ^c   Kim, Hee Sun ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Jeju National University School of Medicine   (South Korea)

Author keywords

AP 1; Glioma invasion; MAP kinases; MMP; NF B; Rh2

Indexed keywords

GELATINASE B; GINSENOSIDE RH 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; STROMELYSIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL INVASION; CONTROLLED STUDY; DNA BINDING; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ASTROCYTOMA; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GINSENOSIDES; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MOLECULAR STRUCTURE; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 35348993755     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.08.015     Document Type: Article

References (44)

1. Kargiotis O., Rao J.S., and Kyritsis A.P. Mechanisms of angiogenesis in gliomas. J Neurooncol 78 (2006) 281-293
2. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3 (2003) 489-501
3. Salhia B., Tran N.L., Symons M., Winkles J.A., Rutka J.T., and Berens M.E. Molecular pathways triggering glioma cell invasion. Expert Rev Mol Diagn 6 (2006) 613-626
4. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10 (2000) 415-433
5. Lakka S.S., Gondi C.S., and Rao J.S. Proteases and glioma angiogenesis. Brain Pathol 15 (2005) 327-341
6. VanMeter T.E., Rooprai H.K., Kibble M.M., Fillmore H.L., Broaddus W.C., and Pilkington G.J. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53 (2001) 213-235
7. Zhao J.X., Yang L.P., Wang Y.F., Qin L.P., Liu D.Q., Bai C.X., et al. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur J Neurol 14 (2007) 510-516
8. Hu B., Jarzynka M.J., Guo P., Imanishi Y., Schlaepfer D.D., and Cheng S.Y. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66 (2006) 775-783
9. Gondi C.S., Lakka S.S., Dinh D.H., Olivero W.C., Gujrati M., and Rao J.S. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 1 (2004) 165-176
10. Kim S.Y., Jung S.H., and Kim H.S. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337 (2005) 510-516
11. Laurent M., Martinerie C., Thibout H., Hoffman M.P., Verrecchia F., Le Bouc Y., et al. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism. FASEB J 17 (2003) 1919-1921
12. Sounni N.E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., et al. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16 (2002) 555-564
13. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16 (2001) S28-S37
14. Park E.K., Choo M.K., Kim E.J., Han M.J., and Kim D.H. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 26 (2003) 1581-1584
15. Kenarova B., Neychev H., Hadjiivanova C., and Petkov V.D. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 54 (1990) 447-454
16. Yun T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523/524 (2003) 63-74
17. Oh M., Choi Y.H., Choi S., Chung H., Kim K., Kim S.I., et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 14 (1999) 869-875
18. Oh J.I., Chun K.H., Joo S.H., Oh Y.T., and Lee S.K. Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells. Cancer Lett 230 (2005) 228-238
19. Kim H.E., Oh J.H., Lee S.K., and Oh Y.J. Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway. Life Sci 65 (1999) 33-40
20. Kim Y.S., and Jin S.H. Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma. Arch Pharm Res 27 (2004) 834-839
21. Fei X.F., Wang B.X., Tashiro S., Li T.J., Ma J.S., and Ikejima T. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 23 (2002) 315-322
22. Surh Y.J., Lee J.Y., Choi K.J., and Ko S.R. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-kappaB and ERK1/2 in mouse skin. Ann NY Acad Sci 973 (2002) 396-401
23. Park S.A., Kim E.H., Na H.K., and Surh Y.J. KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells. Ann NY Acad Sci 1095 (2007) 545-553
24. Bae E.A., Hyun Y.J., Choo M.K., Oh J.K., Ryu J.H., and Kim D.H. Protective effect of fermented red ginseng on a transient focal ischemic rats. Arch Pharm Res 27 (2004) 1136-1140
25. Bae E.A., Han M.J., Choo M.K., Park S.Y., and Kim D.H. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 25 (2002) 58-63
26. Kim H.S., Goncalves N.M., and Henson J.W. Glial cell-specific regulation of the JC virus early promoter by large T antigen. J Virol 74 (2000) 755-763
27. Woo M.S., Jung S.H., Kim S.Y., Hyun J.W., Ko K.H., Kim W.K., et al. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 335 (2005) 1017-1025
28. Jung S.H., Woo M.S., Kim S.Y., Kim W.K., Hyun J.W., Kim E.J., et al. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int J Cancer 118 (2006) 490-497
29. Chintala S.K., Tonn J.C., and Rao J.S. Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 17 (1999) 495-502
30. Nabeshima K., Inoue T., Shimao Y., and Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52 (2002) 255-264
31. Lorenzl S., Albers D.S., Chirichigno J.W., Augood S.J., and Beal M.F. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy. J Neurol Sci 218 (2004) 39-45
32. Mercapide J., Lopez De Cicco R., Castresana J.S., and Klein-Szanto A.J. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 106 (2003) 676-682
33. Bodey B., Bodey Jr. B., Siegel S.E., and Kaiser H.E. Matrix metalloproteinase expression in childhood astrocytomas. Anticancer Res 20 (2000) 3287-3292
34. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., et al. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263 (2001) 209-223
35. Munaut C., Noel A., Hougrand O., Foidart J.M., Boniver J., and Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer 106 (2003) 848-855
36. Sawaya R., Go Y., Kyritisis A.P., Uhm J., Venkaiah B., Mohanam S., et al. Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo. Biochem Biophys Res Commun 251 (1998) 632-636
37. Kondraganti S., Mohanam S., Chintala S.K., Kin Y., Jasti S.L., Nirmala C., et al. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 60 (2000) 6851-6855
38. Lakka S.S., Rajan M., Gondi C., Yanamandra N., Chandrasekar N., Jasti S.L., et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21 (2002) 8011-8019
39. Lim J.H., Wen T.C., Matsuda S., Tanaka J., Maeda N., Peng H., et al. Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root. Neurosci Res 28 (1997) 191-200
40. Lee E., Kim S., Chung K.C., Choo M.K., Kim D.H., Nam G., et al. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 536 (2006) 69-77
41. Lee B.H., Jeong S.M., Ha T.S., Park C.S., Lee J.H., Kim J.H., et al. Ginsenosides regulate ligand-gated ion channels from the outside. Mol Cells 18 (2004) 115-121
42. Park E.K., Choo M.K., Oh J.K., Ryu J.H., and Kim D.H. Ginsenoside Rh2 reduces ischemic brain injury in rats. Biol Pharm Bull 27 (2004) 433-436
43. Jang S., Ryu J.H., Kim D.H., and Oh S. Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides. Neurochem Res 29 (2004) 2257-2266
44. Bae E.A., Han M.J., Kim E.J., and Kim D.H. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 27 (2004) 61-67